Bioanalytical Systems Shares Surge after Q3 Results (BASI)

Shares of Bioanalytical Systems Inc. (NASDAQ: BASI), a contract research company providing drug discovery and development services, have surged in trading today after the company announced its financial results for the third quarter of fiscal 2013. The company returned to profitability in the third quarter as it benefited from a higher gross margin and lower operating expenses.

BASI reported third-quarter operating income of $438,000, compared to an operating loss of $540,000 reported for the same period in the previous year. This was despite the fact that BASI’s revenue for the third quarter of 2013 fell from last year.

For the quarter, BASI reported revenue of $5.6 million, compared to $7.186 million reported for the same period in the previous year. On a sequential basis though, the company’s revenue rose. In the previous quarter, the company had reported revenue of $5.156 million. BASI’s service revenue for the quarter stood at $4.156 million, down 20.1% from the same period in the previous year. On a sequential basis, service revenue rose. Service revenue in the previous quarter stood at $3.667 million. Product revenue fell 27.3% on a year-over-year basis to $1.444 million. The decline was mainly due to lower sales of the company’s Culex automated sampling systems.

The significant improvement in BASI’s bottom-line was mainly due to higher gross margin. For the quarter, the company reported gross margin of 36.3%, compared to 28.7% reported for the same period in the previous year. The company’s bottom-line also benefited from a 19.3% reduction in operating expenses.
Net income for the quarter stood at $576,000, or $0.08 per basic share and $0.07 per diluted share. For the same period in the previous year, the company had posted a net loss of $246,000, or $0.03 per basic and diluted share.

Jacqueline Lemke, President, CEO and CFO of Bioanalytical Systems, said that each of the company’s critical operating metrics, including revenue, gross margin, operating income and cash flow, improved sequentially in the third quarter compared to this year’s second quarter. Lemke noted that on the product side, as previously announced, the company is collaborating with Pinnacle Technology to create a better way to monitor glucose and with Data Sciences International to add value to its Celux system. Lemke believes that the company’s recent contract to provide IND-enabling safety and toxicology studies for NanoViricides Inc. and the preferred provider agreement with G1 Therapeutics provide a solid foundation for generating long-term growth and profitability BASI is striving for.

BASI shares have surged in trading today as investors digested the company’s quarterly results. At last check, the stock was trading 32.65% higher at $1.95 on above average volume of 355,515. BASI shares struck a 52-week high of $2.07 earlier in the day.

BASI shares have broken through some key technical levels as a result of the rally today. The stock is expected to face resistance at around $2. If it breaks through this level then the upward trend in BASI shares could continue.

View to Original post :- Click here

Free Stock Watch List For Monday October 14

Hello Traders and welcome to another premium list of 6 stocks to put on your watch list for Monday October 14. The list below will consist of sub penny stocks right up to $2.00 small cap stocks. Since many of you visiting this link are not on my “SuperNova Elite Premium” list then you will just be watching these stocks as the day(s) go on. My SuperNova Elite Premium members will be a full action plan on which stock if any from the list below we will be trading on Monday. On several occasions our “Alerts” will come right from this “Watch List” but on other occasions we find other stocks that come up live during market hours that look more action ready.

As you know by now, my SuperNova Elite Premium list will be alerted to all buy and sells via email, live chat room and of course cell phone text message. This allows members to be at work, at the gym, out shopping or right at home and still be able to take action when I see a appropriate stock.

These “Watch Lists” are giving Sunday through Friday to my SuperNova Elite Premium members. In addition they get access to the largest penny stock chat room available right now. I have 4 assistants that help me run this chat room which is not only used as a live learning environment for new traders but its used as a excellent scalp trading and short term trading room. With over 400 traders utilizing this chat room on a daily basis, there is no stock that goes unnoticed!

SuperNova Elite Premium members also gain access to my educational video library of over 110 lessons that are valued at $7,000 plus and growing. You can preview these lessons by clicking here.

As you can see, the value of my service is second to none. Many other services out there charge $100′s of dollars just for a chat room alone or $5,000 just for educational material. SuperNova Elite members get everything I have to offer for just about $3 a day.

View to Original post :- Click here

NASDAQ Stock on Watch; MER Telemanagement Solutions Ltd. (MTSL)

Equity markets struggled on Tuesday as concerns over a possible U.S. debt-default weighed down sentiment. All three indexes posted losses on Tuesday, snapping a three-day winning streak. Although the broad market struggled, shares of MER Telemanagement Solutions Ltd. (NASDAQ: MTSL), a worldwide provider of solutions for telecommunications expense management (TEM) and billing solutions, surged.
The rally in TEM shares was sparked after the Israel-based company announced that it signed a three-year agreement with SBC Communications LLC, a U.S.-based service provider of Internet, cable TV, home phone and wireless services. Under the terms of the agreement, MTSL will provide its cloud and managed services Mobile Virtual Network Enabler (MNVE) solution.

MTSL’s MVNE managed services and cloud solution offers established and new MVNOs like SBC Communications an ideal service platform to enable a quick market penetration, flexible personalization, and rapid systems integration into any business operation.

Commenting on the agreement, Fabio Campagna, Director of Business Development-MNVE at MTSL, said that the company is very excited to be selected by SBC Communications as its new MNVO partner and looks forward to providing them with its proven MNVE solution that will optimize business operations and provide them with a full suite of advanced features and services.

The agreement with SBC Communications comes after MTSL’s TEM Suite received a 2012 Communications Solutions Product of the Year Award from TMC and the editors of Internet Telephony and Customer magazines.

John Venditti, VP of Marketing at MTSL, said that the continued growth and complexity of communication technologies within the enterprise has created a demand for a solution that can manage all facets of a wireline and wireless telecom lifecycle from policy compliance to cost optimization and security management.
MTSL reported its most recent quarterly results (Q2) back in August. For the second quarter, the company reported revenue of $3.1 million, compared to $3.3 million reported for the same period in the previous year. The company’s operating profit for the quarter was $377,000, compared to $517,000 reported for the same period in the previous year. Net income for the quarter came in at $309,000, or $0.07 per share, compared to $460,000, or $0.10 per share reported for the same period in the previous year.

Revenue for the six-month period ended June 30, 2013 was $6.4 million, up from $6.3 million reported for the same period in the previous year.

Eytan Bar, CEO of MTSL, said following the release of second-quarter results that the company is seeing opportunities in the TEM, MVNE and Mobile Money markets and is working diligently to convert the opportunities into new contracts. The significant progress made by MTSL has been noticed by investors, and on Tuesday, the company’s shares surged to an intra-day high of $3.44. The stock pared some of its gains later in the day as the broader market struggled. However, it still finished 46.73% higher at $2.70.
MTSL shares broke through $2.20 resistance level on Tuesday. The stock also crossed above its 50-day and 200-day moving averages as a result of the rally. The MACD chart suggests that the upward trend could continue.

View to Original post :- Click here

Cereplast Receives Major Purchase Order; Shares Surge

Cereplast Inc. (OTC: CERP), a company engaged in the development and commercialization of bio-based resins, has seen a sharp rise in its shares in trading today. The rally has been sparked after the company announced the receipt of a $1.4 million purchase order for its Biopropylene® 101.

CERP’s Biopropylene 101 is part of the Cereplast Sustainables® family of resins. The product maintains most of the desirable conventional Polypropylene properties such as chemical resistance, mold shrinkage, mold flow, surface appearance, heat deflection temperature and hinge performance. However, when compared to Polypropylene, Biopropylene provides a lower carbon footprint. Given the increasing demand for environmentally friendly products, Biopropylene has a bright outlook.

Earlier today, Cereplast announced that it received a $1.4 million purchase order for its Biopropylene 101 from Dugar Eximark Private Limited, a Hyderabad, India-based company. The company will sell the material from its existing inventory. The order will be shipped from Europe over the next 10 months.

Commenting on the purchase order, Frederic Scheer, Chairman and CEO of Cereplast, said that entering into an agreement to liquidate existing inventory is a critical milestone for the company. Scheer further said that from a financial perspective, the transaction yields strong cash flow over the next 10 months due to the sale of existing product already manufactured. He added that in the company’s continued effort to build its footprint in India, it is encouraged by the continued partnership it has built with Dugar Eximark.

While the company is building its footprint in India, it is also hoping for positive developments in other parts of the world, especially in Europe. Back in April, the Italian government signed and published a decree inflicting sanctions on bags made from traditional plastics. However, in May, the U.K. government filed an opposition with the European Union (EU), claiming that Italy was breaching EU internal market rules. This has led to some delay.

CEO Scheer noted that the passing of the September 12, 2013 date without an update from the EU has left the EU market in a state of confusion in terms of what the status of the legislation is. Scheer noted that when dealing with a governing body, delays are to be expected. However, he remains confident that there will be resolution in the near-term.

For the first half of 2013, Cereplast reported net revenue of $1.7 million, significantly above the $305,000 reported for the same period in the previous year. In fact, the company’s first half revenue is higher than the revenue reported for the whole of 2012. In 2012, CERP’s total revenue was $911,000.
CERP shares have surged in trading today. At last check, the stock was trading 26.32% higher at $0.0168 on above average volume of 30.32 million.

CERP shares have broken through their 50-day moving average in trading today as a result of the rally. The stock’s MACD has also crossed above the signal line. Both of these are strong bullish signals, and suggest that the upward momentum in CERP shares could continue, going forward.

View to Original post :- Click here